Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P212: Diagnostic approach to monogenic inflammatory bowel disease in clinical practice: a 10-year multi-centric experience

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Lega*1, A. Pin1, S. Arrigo2, C. Cifaldi3, M. Girardelli1, A. Bianco1, M. Malamisura4, G. Angelino4, S. Faraci4, E. F. Romeo4, B. Papadatou4, M. Miano5, M. Aloi6, G. Magazzù7, C. Romano7, P. Calvo8, A. Barabino2, S. Martelossi1, A. Tommasini1, G. Di Matteo3, C. Cancrini3, P. De Angelis4, A. Finocchi3, M. Bramuzzo1

1Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy, 2Institute Giannina Gaslini, Pediatric Gastroenterology and Endoscopy Unit,, Genoa, Italy, 3Children’s Hospital Bambino Gesù, Department of Pediatrics, Rome, Italy, 4Children’s Hospital Bambino Gesù, Digestive diseases Unit, Rome, Italy, 5Institute Giannina Gaslini, Pediatric Hematology-Oncology Unit, Genoa, Italy, 6Sapienza University of Rome, Pediatric Gastroenterology And Liver Unit, Rome, Italy, 7University of Messina, Pediatric Gastroenterology and Cystic Fibrosis Unit, Messina, Italy, 8Azienda Ospedaliera-Universitaria Città della Salute e della Scienza di Torino, Pediatric Gastroenterology Unit, Turin, Italy

P213: Raised faecal calprotectin in inflammatory bowel disease (IBD) patients: 100% accurate or potential red herring?

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Christopher*1, C. Clifford1, C. White1, E. Anderson1, J. Keohane1, S. Sengupta1

1Our Lady of Lourdes Hospital, Drogheda, Department of Gastroenterology and Clinical Medicine, Drogheda, Ireland

P214: How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Casellas*1, D. Ginard2, S. García-López3, Y. González-Lama4, F. Arguelles-Arias5, M. Barreiro-de Acosta6, L. Marín Sánchez7, J. M. Mendive8, R. Saldaña9

1Hospital Universitari Vall d'Hebron, Servicio Digestivo, Barcelona, Spain, 2Hospital Universitario Son Espases, Servicio Digestivo, Palma de Mallorca, Spain, 3Hospital Universitario Miguel Servet, Servicio Digestivo, Zaragoza, Spain, 4Hospital Universitario Puerta de Hierro-Majadahonda, Unidad Enfermedad Inflamatoria Intestinal, Madrid, Spain, 5Hospital Universitario Virgen Macarena, Aparato Digestivo, Sevilla, Spain, 6Hospital Clínico Universitario de Santiago de Compostela, Unidad Enfermedad Inflamatoria Intestinal, Santiago de Compostela, Spain, 7Hospital Universitario Germans Trias i Pujol, Badalona, Unidad Enfermedad Inflamatoria Intestinal, Badalona, Spain, 8La Mina Primary Care Centre, Sant Adrià de Besós, Spain, 9ACCU España, Gerencia, Madrid, Spain

P215: The mean platelet volume compared with other serum biomarkers: is it predictive of activity of Crohn’s disease?

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Ben Jeddi*1, H. Kchir1, A. Hassine1, D. Issaoui1, H. Chaabouni1, N. Maamouri1

1La Rabta Hospital, Gastroenterology B, Tunis, Tunisia

P216: Impact of disease knowledge on quality of life of inflammatory bowel disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Casellas*1, E. Navarro1, C. Herrera-deGuise1, V. Robles1, N. Borruel1

1Unitat Atenció Crohn-Colitis, Hospital Universitari Vall d'Hebron, Barcelona, Spain

P217: Serological biomarkers of type VI collagen remodelling reflect endoscopically and clinically active Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Lindholm*1,2, L. E. Godskesen2, J. Kjeldsen2, A. Krag2, M. A. Karsdal1, T. Manon-Jensen1, J. H. Mortensen1

1Nordic Biosciene A/S, Biomarkers & Research, Herlev, Denmark, 2University of Southern Denmark and Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark

P218: The cost-effectiveness of biological therapy cycles in the management of Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Bolin*1, E. Louis2, E. Hertervig3

1Centre for Health Economics, Department of economics, University of Gothenburg, Gothenburg, Sweden, 2University Hospital CHU of Liège Belgium, Department of Gastroenterology, Liège, Belgium, 3Skane University Hospital, Lund, Department of Gastroenterology, Lund, Sweden

P219: Retrospective investigation of tacrolimus combined with an anti-TNFα antibody as remission induction therapy for refractory ulcerative colitis: efficacy, safety, and relapse rate

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Ito*1, S. Murasugi1, N. Matsuo1, K. Tani1, T. Omori1, M. Itabashi1, K. Tokushige1

1Tokyo Women’s Medical University, Tokyo, Japan

P220: IBIS-Q (IBd Identification of Spondyloarthrytis Questionnaire): a new tool to detect spondyloarthritis in inflammatory bowel diseases

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Variola*1, M. Di Ruscio1, A. Geccherle1, A. Pasetti2, G. Cipriano3, E. Zanolin4, A. Marchetta5, I. Tinazzi5

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2University of L'Aquila, Gastroenterology Unit, L'Aquila, Italy, 3IRCCS Sacro Cuore Don Calabria, Pharmacy, Negrar, Italy, 4University of Verona, Epidemiology and medical statistics, Verona, Italy, 5IRCCS Sacro Cuore Don Calabria, Rheumatology, Negrar, Italy

P221: Drug survival of biologics in ulcerative colitis treatment in Norway

ECCO '19 Copenhagen

Year: 2019
Authors:

S. S. Lirhus*1, M. Lie Høivik2, B. Moum2, H. O. Melberg1

1The University of Oslo, Department of Health Management and Health Economics, Oslo, Norway, 2Oslo University Hospital, Department of Gastroenterology, Oslo, Norway

P222: Purely fibrostenotic Crohn’s disease without chronic inflammation is uncommon – a histopathologic study of resected intestine

ECCO '19 Copenhagen

Year: 2019
Authors:

U. N. Shivaji*1,2, M. Evans3, T. Critchlow4, S. C. L. Smith2, M. Iacucci1,2, S. Ghosh1,2, R. Cooney4, K. Skordilis3

1National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Immunology and Immunotherapy, Birmingham, UK, 2Institute of Translational Medicine, Gastroenterology, Birmingham, UK, 3University Hospitals Birmingham, Pathology, Birmingham, UK, 4University Hospitals Birmingham, Gastroenterology, Birmingham, UK

P223: Efficacy and safety of tacrolimus in Crohn’s disease: a nationwide, multi-centric study from GETECCU

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Rodriguez-Lago*1, J. Castro-Poceiro2, A. Fernández-Clotet2, F. Mesonero3, A. López-Sanromán3, A. López-García4, L. Márquez4, A. Clos-Parals5, F. Cañete5, M. Vicuña6, Ó. Nantes6, O. Merino7, V. Matallana Royo8, J. Gordillo9, A. Elorza1, P. Sanz10, M. J. Casanova11,12, R. Ferreiro-Iglesias13, P. Pérez-Galindo14, J. M. Benítez15,16, C. Taxonera17, M. J. García García18, E. Martín Arranz19, M. Calafat20, A. Martín-Cardona21,22, F. Muñoz Núñez23, J. O. Miquel-Cusachs24, E. Sáinz Arnau25, J. P. Gisbert11, Young IBD Group from GETECCU1

1Hospital de Galdakao, Gastroenterology, Galdakao, Spain, 2Hospital Clinic, Gastroenterology, Barcelona, Spain, 3Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain, 4Hospital del Mar, Gastroenterology, Barcelona, Spain, 5Hospital Universitario Germans Trias i Pujol, Gastroenterology, Badalona, Spain, 6Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain, 7Hospital de Cruces, Gastroenterology, Bilbao, Spain, 8Hospital Universitario Puerta de Hierro, Gastroenterology, Majadahonda, Spain, 9Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain, 10Hospital Universitario Miguel Servet, Gastroenterology, Zaragoza, Spain, 11Hospital Universitario de La Princesa, Gastroenterology, Madrid, Spain, 12Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, 13Hospital Clínico Universitario de Santiago de Compostela, Gastroenterology, Santiago de Compostela, Spain, 14Hospital Montecelo, Gastroenterology, Pontevedra, Spain, 15Hospital Universitario Reina Sofía, Gastroenterology, Córdoba, Spain, 16IMIBIC, Córdoba, Spain, 17Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain, 18Hospital Marqués de Valdecilla, Gastroenterology, Santander, Spain, 19Hospital Universitario La Paz, Gastroenterology, Madrid, Spain, 20Hospital Son Llàtzer, Gastroenterology, Palma, Spain, 21Hospital Universitari Mutua Terrassa, Gastroenterology, Terrassa, Spain, 22Centro de Investigación biomédica en red de enfermedades hepáticas y digestivas (CIBERehd), Terrassa, Spain, 23Hospital de Salamanca, Gastroenterology, Salamanca, Spain, 24Hospital Universitario de Girona, Gastroenterology, Girona, Spain, 25Hospital Arnau de Vilanova, Gastroenterology, Lérida, Spain

P224: Responder definitions for the ulcerative colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) tool using patients with ulcerative colitis treated with etrolizumab

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Higgins*1, A. Matsui2, K. DeBusk2, J. Pulley3, A. Scalori3, Y. S. Oh2, U. Arulmani2

1University of Michigan, Ann Arbor, USA, 2Genentech, South San Francisco, USA, 3Roche, Burgess Hill, UK

P225: Day of admission results predict failure of first-line treatment in acute ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Grant*1, R. Lynch1, S. Bouri2, A. Elosua González2,3, T. Manship4, F. Jagger4, M. Shivakumar5, J. Satsangi6, G-T. Ho4, C. Lees4, N. Plevris4, P. Tozer2, A. Hart2, I. Arnott4

1Royal Infirmary of Edinburgh, Edinburgh, UK, 2St Mark's Hospital, Harrow, UK, 3Complejo Hospitalario de Navarra, Navarra, Spain, 4Western General Hospital, Edinburgh, UK, 5University of Edinburgh, Edinburgh, UK, 6University of Oxford, Oxford, UK

P226: Systematic review with meta-analysis of individual data: impact of cut-off values on the performance of faecal calprotectin to detect endoscopic recurrence after intestinal resection in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Kirchgesner1, G. Boschetti2, A. Buisson3, T. Yamamoto4, E. Domenech5, S. Nancey2, L. Peyrin-Biroulet6, M. Uzzan*7

1Saint-Antoine Hospital, Paris, France, 2CH Lyon-Sud, Lyon, France, 3CHU Estaing, Clermont-Ferrand, France, 4Yokkaichi Hazu Medical Center, Yokkaichi, Japan, 5Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 6CHU Nancy, Vandoeuvre Les Nancy, France, 7Hopital Beaujon, Clichy, France

P227: Association between pouchitis and faecal calprotectin following restorative proctocolectomy in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Fujimori*1,2, M. Uchino2, H. Ikeuchi2, T. Masaki1

1Kagawa University, Department of Gastroenterology and Neurology , Faculty of Medicine, Takamatsu, Japan, 2Hyogo collage of Medicine, Department of Inflammatory Bowel Disease , Division of surgery, Nishinomiya, Japan

P228: Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Fabris1,2, F. Meroi3, A. Cifu'2, E. Castagnaviz3, F. Curcio1,2, G. Terrosu4,5, G. Scardino3, S. F. Vadalà di Prampero3, M. Marino*3

1University Hospital of Udine, Istituto di Patologia Clinica, Udine, Italy, 2University Hospital of Udine, Dipartimento di Area Medica, Udine, Italy, 3University Hospital of Udine, Gastroenterology, Udine, Italy, 4University Hospital of Udine, General Surgery and Transplantation Unit, Udine, Italy, 5University Hospital of Udine, Department of Medical and Biological Sciences, Udine, Italy

P229: The relationship between computed tomography enterography findings and levels of faecal biomarkers in patients with small bowel Crohn’s disease: A prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Shimoyama*1, T. Yamamoto1, S. Umegae1, K. Matsumoto1

1Yokkaichi Hazu Medical Centre, IBD Centre, Yokkaichi, Japan

P230: Prediction of loss of response to anti-TNF therapy using SES-CD in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. Fuyuno*1, T. Torisu1, A. Hirano1, S. Fujioka1,2, J. Umeno1, T. Moriyama1,3, T. Kitazono1, M. Esaki4

1Kyushu University, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Fukuoka, Japan, 2Kyushu University Hospital, Department of Endoscopic Diagnostics and Therapeutics, Fukuoka, Japan, 3Kyushu University Hospital, International Medical Department, Fukuoka, Japan, 4Saga University Hospital, Department of Endoscopic Diagnostic and Therapeutics, Saga, Japan

P231: CECDAIic: a new score for panenteric evaluation in Crohn’s disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Arieira*1,2,3, R. Magalhães1,2,3, F. Dias de Castro1,2,3, P. Boal Carvalho1,2,3, B. Rosa1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

1Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal, 2Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga/Guimarães, Portugal, 3ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal